WILMINGTON – Life science servicecs provider PPD is going out with a bang as the Wilmington-based company with a big presence in the Research Triangle prepares to be acquired by Thermo Fisher.
“I’m delighted to report that our strong momentum across the business continued in the second quarter,” said David Simmons, PPD’s chairman and CEO, about PPD’s latest financial report.
“In addition to achieving solid growth in net authorizations, our colleagues’ commitment to delivering for customers helped drive significant revenue growth. With our differentiated capabilities, deep customer relationships and culture of quality and innovation, we remain well positioned for ongoing success as we look forward to the anticipated merger with Thermo Fisher Scientific.”
PPD’s numbers show how far the company has come in recovering from the impact of the pandemic:
- Revenue of $1,575.5 million, representing growth of 55.8% over second quarter 2020
- Net income attributable to common stockholders of $58.7 million, compared to a net loss attributable to common stockholders of $9.1 million in second quarter 2020
- Adjusted EBITDA of $257.4 million, compared to $194.4 million in second quarter 2020
- Diluted earnings per share of $0.16, compared to a diluted loss per share of $0.03 in second quarter 2020
- Adjusted diluted earnings per share of $0.39, compared to $0.25 in second quarter 2020
PPD and Thermo Fisher announced their merger in April. The deal has yet to close.